Graduated from Nanjing Xiaozhuang Normal University, engaged in monoclonal antibody, double clonal antibody and fusion protein process development work, has 14 years of professional experience. During this period, he has been involved in more than 20 different varieties of biopharmaceutical projects, including process development research and declaration, as well as the production of clinical samples. These projects cover the whole process from laboratory research to 2000L scale production, providing important support for the development and marketing of new drugs. After joining Nanjing Aoke Immune Technology Co., LTD., he was mainly responsible for the upstream and downstream process development of antibodies and fusion proteins, including optimizing the production process, improving the yield and quality of products, and developing and improving the formulation.